{"name":"Exegi Pharma, LLC","slug":"exegi-pharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxQbU9uUkl4TVNYRDNuSDlmaFpEZUdrRWcxcTJMU21tUE9tVGhVLVA0b3FyRWl0LVRnNG1aU1JhNHZxWmhvNXAweVBCSVFiUjAyeFZ6OWhlT2xhUXNUYmFDTVp3aGdlR3BVcFRobkdtYVpQOFdOR1kxUUZKTWpaTnZBN3FQUW9xSHEwOGltQlhNVXhnZHQzMlVnWHdPNkE4MjZheHpwdnJHLUdVQ2tPNXplWE9sNy1CcGp5bjZTTm0yMVNpNXpDbEVJRGphZUkwWVlMVkREWjRuUVR5cnNGLXZUWTJvTXJFNDlHazJ3?oc=5","date":"2026-02-23","type":"pipeline","source":"prnewswire.com","summary":"New ACVIM Consensus Statement Highlights Visbiome Vet's De Simone Formulation in Diet-First Approach - prnewswire.com","headline":"New ACVIM Consensus Statement Highlights Visbiome Vet's De Simone Formulation in Diet-First Approach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNaDM0RV9EU1ZYcjFpRHg0ZHphTWV2dzBvUTVZcW5YMHU0ZThCdHhVV1llWjdEamxvejc2SVI1aEZ6RkZiMXF3bmhCYWJuQjVJM3ZjdnpNeFVfUmdkM0ZpeTNCSktaT180bFo3TTZBa19qUTlFNk9yZzFhaGNlMENXWU05MTI0cm9KdHFv?oc=5","date":"2025-11-19","type":"pipeline","source":"Yahoo! Finance Canada","summary":"ExeGi Pharma Launches Visbiome Vet GI Care+ in Canada - Yahoo! Finance Canada","headline":"ExeGi Pharma Launches Visbiome Vet GI Care+ in Canada - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOcWJfbDl4V3pVMHJMclFHT2taVDNHb25nYUFMcllpQXpBOENDZGE5YnFoR0s1QTFnWUJiLVpjZDZNU2x5aU5Pc0RleDRzam5zVDEzOXpObVdIb2NxMFpJX3hzdDJxZERmNUU4VlVYYU10Q2JqVFdGQkJBZWVQZFkwWUxPd3NFalFkTVdTRjhjaXhISlkzcEZyaVlxMXNJZWpubVJaRFg4SnRPWGI4R2RiNkdTR2c3RWFLNEVLeVBieFByUjY2WGVYbXJ4RFpYQkI4UXlYaHkzdWFsOEw1am52Nw?oc=5","date":"2025-03-20","type":"pipeline","source":"prnewswire.com","summary":"Makers of Visbiome Vet Earn NASC Quality Seal for Commitment to Excellence in Animal Health - prnewswire.com","headline":"Makers of Visbiome Vet Earn NASC Quality Seal for Commitment to Excellence in Animal Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPeEwtNVJjaVlIcGF3d2E5Y0VUaWZfZmoxTlBHajZlNExSUmY2Z3psaFFnaXlTZkFXYTZ5ZkpCelNScGhCVkQ2VmxTTGJIZW12aWNGeGkxVU1IUTQzSS1SRGptWGNobFNBTk9TbzFiYXBQX2x2REhXZ1lpTXY0VWtKSHd2OHBQTTU0dFBhTldlX3loMGdoOTM1Q3ptY3c0aWpycVN4Y0p3aTZuM09DRmtYRGdqcFF5d1M2R2dLbVhVWHduQQ?oc=5","date":"2024-12-17","type":"trial","source":"prnewswire.com","summary":"ExeGi Pharma Positive Topline Results in EXE-346 PROF Phase 1b Study - prnewswire.com","headline":"ExeGi Pharma Positive Topline Results in EXE-346 PROF Phase 1b Study","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxQVEQ0OTVHYnQ4RzRzR1VVQTFHMkhoN19fZHNRS1dNelRaaVlTTnNpN0NjVzEwQUgzSmpBdHBHcVR1c3l4a09wZl8xeTRUcjFJUm5TWWNqbWlTdkN3UkI5WFl3dm1McDBkR3BndENZLTlqVF92czdJcV9udDduVllrTC1UTTEzUGxsXzlzX3BaeFpweFBzNkdVLVFldWF3MXlsUnVBUERvZXB2eWtPczkxS2d3a2hiMS1MLXV1Z1dEUThkUzdITmhEbnRPTUdFZGpNanFTcmNRMDdtemNXUVhvaVdVYkpfWHRBSS1BZ3dHMUYxU1U0TzlHcTctdUxNbFctSVlvLXpOdjF4UQ?oc=5","date":"2023-12-06","type":"pipeline","source":"IANS","summary":"Indo-Asian News Service - IANS","headline":"Indo-Asian News Service","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE9GSTc2VnhNS01HOGpTZmhmVF8tSjFNV0pRNXk2Z3BjMXRfSy1HMm1mYXc4V2lLQ3JwdTVjR3lNbExmTVBERVk1SGhRa3hPTWlwVF84S2JoRlE4OXAyWFlGZFo2dTROX2h4N1R0aW84Rm9nM28?oc=5","date":"2023-01-27","type":"regulatory","source":"Labiotech.eu","summary":"FDA clearance for ‘revolutionary’ approach to J-Pouch issue - Labiotech.eu","headline":"FDA clearance for ‘revolutionary’ approach to J-Pouch issue","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQUl8zN3VUUjlTR0pGaG9VbU1zcmNhZDJWMmpMb05FYXh4eGp2RjUtbkt6UVhNWjBGNTB2SWxXVHMxbk5HUW8zYmJVT3AyLWxCalhZajFFZ0d0ZnlFNVJpMlllZGxzdjF4blkyWTlWU2lYbVpSVk5WZlBlSWNhdG43cXI4dGlZV19vUmdkWk51ZVRDSlAtOV8yNA?oc=5","date":"2019-09-09","type":"pipeline","source":"BioSpace","summary":"ExeGi Pharma Probiotics to be Studied in Multiple Sclerosis Patients - BioSpace","headline":"ExeGi Pharma Probiotics to be Studied in Multiple Sclerosis Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE9hWDZiY0tsQ0JRaTd4cWtCd21WcUd2bVF5NU9qMzZtaUkwS2otV3gweGsydUQ3a0pBRzk3dk1QS2gwYkI2X1pKREt1YkJvYzdtOGU0NXhseEQyN2cwTzBDaTltUWJ4ekc2T0pjczl4X1RONTA?oc=5","date":"2016-02-01","type":"pipeline","source":"BioSpace","summary":"ExeGi Pharma Launches Visbiome Probiotic - BioSpace","headline":"ExeGi Pharma Launches Visbiome Probiotic","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}